Relationship of arterial hypertension, metabolic syndrome with vitamin D deficiency in women
Objective: To assess the relationship between vitamin D deficiency (VD) and risk factors for metabolic syndrome (MS) in postmenopausal women with arterial hypertension (AH). Materials and methods of research. The study included 46 women aged 45–65 years with amenorrhea > 12 months, having grade 1 hypertension and metabolic syndrome. Anthropometric, laboratory and instrumental data were studied. Biochemical parameters included total cholesterol (OH), HDL, triglycerides, glucose, insulin, and 25-hydroxyvitamin-D [25 (OH)D]. Daily blood pressure monitoring was performed according to the standard protocol. Levels of 25(OH)D in blood serum was classified as-adequate (≥ 30 ng/ml) and insufficient (20–29 ng/ml). Results: Level 25 (OH)D in blood serum was sufficient in 21 women (45.6 %), insufficient – in 25 (54.4 %). Women with insufficient levels of 25 (OH)D had higher levels of cholesterol, triglycerides, insulin, and HOMA-IR. Metabolic syndrome was detected in 64 % (16/25) of women with hypovitaminosis D and in 43 % (9/21) of women with sufficient VD (p < 0.01). The correlation analysis established the relationship of the low level of 25 (OH)D (< 30 ng / ml) with MS (r = 0.68), high triglycerides (r = 0.74) and low HDL (r = 0.71). The average concentration of 25 (OH) D decreased with an increase in the number of MS components (p = 0.016). Conclusions: VD deficiency in postmenopausal women was associated with a higher prevalence of MS. Women with HDL deficiency had a higher risk of MS, hypertriglyceridemia, and low HDL levels compared to those with adequate levels.
Vasilieva L.V., Tatarintseva Y.V., Gosteva E.V., Popov S.Y. 2020. Relationship of arterial hypertension, metabolic syndrome with vitamin D deficiency in women. Challenges in Modern Medicine, 43 (4): 549–559 (in Russian). DOI: 10.18413/2687-0940-2020-43-4-549-559
While nobody left any comments to this publication.
You can be first.
Alekseeva N.S. 2016. Vlijanie deficita i nedostatochnosti vitamina d na razvitie metabolicheskogo sindroma [The effect of vitamin d deficiency and insufficiency on the development of metabolic syndrome]. Mediko-farmacevticheskij zhurnal «Pul's», 18 (9): 43–47 (in Russian).
Alekjan B.G., Alehin M.N., Alshibaja M.M., Andreev D.A., Aslanidi I.P., Babenko S.I., Bazaev V.A., Belkina M.V., Bespalova E.D., Bogdanov A.R., Bokerija O.L., Buziashvili Ju.I., Buslenko N.S., Vasil'eva E.Ju., Vasjuk Ju.A., Vishnjakova M.V., Giljarov M.Ju., Gorbachevskij S.V., Grabskaja E.A., Darvish N.A. i dr., 2011. Klinicheskaja kardiologija: diagnostika i lechenie [Clinical cardiology: diagnosis and treatment]. V 3-h tomah / Moskva, Tom 1 (in Russian).
Bunova S.S., Zhernakova N.I., Fedorin M.M., Skirdenko Ju.P., Osipova O.A. 2020 Jeffektivnaja antigipertenzivnaja terapija: fokus na upravlenie priverzhennost'ju [Effective antihypertensive therapy: focus on commitment management]. Kardiovaskuljarnaja terapija i profilaktika. 5 (19): 259–266 (in Russian).
Vorob'ev R.I., Sharlaeva E.A., Vorob'eva E.N., Sokolova G.G., Kazyzaeva A.S., Rudakova D.M., Efremushkina A.A. 2016. Osobennosti lipidnogo obmena i chastota vstrechaemosti dislipidemij u gorodskih zhitelej [Features of lipid metabolism and the frequency of dyslipidemia in urban residents]. Ul'janovskij mediko-biologicheskij zhurnal, 3: 35–43 (in Russian).
Diagnostika, lechenie, profilaktika ozhirenija i associirovannyh s nim zabolevanij (nacional'nye klinicheskie rekomendacii) [Diagnosis, treatment, and prevention of obesity and associated diseases (national clinical guidelines)]. Sankt-Peterburg, 2017 (in Russian).
Zheltikova T.M., Denisov D.G., Mokronosova M.A. 2019. Gendernye i vozrastnye osobennosti statusa vitamina D (25(ON)D) v Rossii [Gender and age characteristics of vitamin d status (25 (OH)D) in Russia]. RMZh, 12: 51–56 (in Russian).
Nedogoda S.V., Barykina I.N., Hripaeva V.Ju, Salasjuk A.S., Smirnova V.O. 2014. Metabolicheskie narushenija u zhenshhin v postmenopauze i sposoby ih korrekcii [Metabolic disorders in postmenopausal women and ways to correct them]. Lekarstvennyj vestnik, 3 (55): 10–18 (in Russian).
Canava I.A., Sharonova L.A., Verbovoj A.F. 2017. Metabolicheskij sindrom i serdechno-sosudistye zabolevanija [Metabolic syndrome and cardiovascular diseases]. RMZh, Medicinskoe obozrenie, 11: 785–789 (in Russian).
A Global Brief on Hypertension. [(accessed on 30 October 2017)]; Available online: http://apps.who.int/iris/bitstream/10665/79059/1/WHO_DCO_WHD_2013.2_eng.pdf.
Cho E.J., Min Y.J., Oh M.S., Kwon J.E., Kim J.E., Lee W.S., Lee K.J., Kim S.W., Kim T.H., Kim M.A., Kim C.J., Ryu W.S. 2011. Effects of the transition from premenopause to postmenopause on lipids and lipoproteins: quantification and related parameters. Korean J. Intern. Med., Mar; 26 (1): 47–53. doi: 10.3904/kjim.2011.26.1.47.
Duparc T., Ruidavets J.B., Genoux A., Ingueneau C., Najib S., Ferrières J., Perret B., Martinez L.O. 2020. Serum level of HDL particles are independently associated with long-term prognosis in patients with coronary artery disease: The GENES study. Sci Rep. May 18; 10 (1): 8138. doi: 10.1038/s41598-020-65100-2.
Farrell C.J., Herrmann M. 2013. Determination of vitamin D and its metabolites. Best Pract. Res. Clin. Endocrinol. Metab., 27: 675–688. doi: 10.1016/j.beem.2013.06.001.
Frankenberg A.D.V., Reis A.F., Gerchman F. 2017. Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes: a literature review. Arch. Endocrinol. Metab. Dec; 61 (6): 614–622. doi: 10.1590/2359-3997000000316.
Geleijnse J.M. 2011. Vitamin D and the Prevention of Hypertension and Cardiovascular Diseases: A Review of the Current Evidence. Am. J. Hypertens., 24: 253–262. doi: 10.1038/ajh.2010.199.
George J.A., Norris S.A., van Deventer H.E., Crowther N.J. 2013. The association of 25 hydroxyvitamin D and parathyroid hormone with metabolic syndrome in two ethnic groups in South Africa. PLoS One, 8 (4): e61282. Published 2013 Apr 15 doi: 10.1371/journal.pone.0061282.
Girona J., Amigó N., Ibarretxe D., Plana N., Rodríguez-Borjabad C., Heras M., Ferré R., Gil M., Correig X., Masana L. 2019. HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk. Int. J. Mol. Sci. Jun 27; 20 (13): 3151. doi: 10.3390/ijms20133151.
Kim S., Limb J., Kyec S., Joung H. 2012. Association between vitamin D status and metabolic syndrome risk among Korean population: based on the Korean National Health and Nutrition Examination Survey IV–2, 2008. Diabetes Res. Clin. Pract., 96: 230–236.
Legarth C., Grimm D., Wehland M., Bauer J., Krüger M. 2018. The Impact of Vitamin D in the Treatment of Essential Hypertension. Int. J. Mol. Sci., 19 (2): 455. Published 2018 Feb 3. doi:10.3390/ijms19020455.
Majeed F. 2017. Low levels of Vitamin D an emerging risk for cardiovascular diseases: A review. Int. J. Health. Sci. (Qassim), 11 (5): 71–76.
McMullan C.J., Borgi L., Curhan G.C., Fisher N., Forman J.P. 2017. The effect of vitamin D on renin-angiotensin system activation and blood pressure: a randomized control trial. J. Hypertens., 35 (4): 822–829. doi:10.1097/HJH.0000000000001220.
Park Y.W., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., Heymsfield S.B. 2003. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Archives of internal medicine, 163 (4): 427–436. https://doi.org/10.1001/archinte.163.4.427.
Płaczkowska S., Pawlik-Sobecka L., Kokot I., Piwowar A. 2018. Estimation of metabolic factors related to insulin resistance and metabolic syndrome in young people. Scand. J. Clin. Lab. Invest. Jul; 78 (4): 325–332. doi: 10.1080/00365513.2018.1469787.
Schmitt E.B., Nahas-Neto J., Bueloni-Dias F., Poloni P.F., Orsatti C.L., Petri Nahas E.A. 2018. Vitamin D deficiency is associated with metabolic syndrome in postmenopausal women. Maturitas.,107: 97–102. doi: DOI:https://doi.org/10.1016/j.maturitas.2017.10.011.
Shamardl H.A., El-Ashmony S.M., Kamel H.F., Fatani S.H. 2017. Potenial Cardiovascular and Renal Protective Effects of Vitamin D and Coenzyme Q10 in l-NAME-Induced Hypertensive Rats. Am. J. Med. Sci., 354: 190–198. doi: 10.1016/j.amjms.2017.04.007.
Song J., Kim E., Shin C., Kim S. S., Lee H.K., Jung M., Jung S.C., Jo S.A. & Jo I. 2004. Prevalence of the metabolic syndrome among South Korean adults: the Ansan study. Diabetic medicine : a journal of the British Diabetic Association, 21 (10): 1154–1155. https://doi.org/10.1111/j.1464-5491.2004.01399.x.
Valer-Martinez A., Martinez J.A., Sayon-Orea C., Galvano F., Grosso G., Bes-Rastrollo M. 2019. Vitamin D and Cardio-Metabolic Risk Factors in Overweight Adults: An Overview of the Evidence. Curr. Pharm. Des., 25 (22): 2407–2420. doi: 10.2174/1381612825666190722103919.
Yoon P.W., Bastian B., Anderson R.N., Janet L. Collins, Harold W. Jaffe. 2014. Centers for Disease Control and Prevention (CDC). Potentially preventable deaths from the five leading causes of death – United States, 2008–2010. MMWR Morb. Mortal. Wkly. Rep., 63 (17): 369–74. PMID: 24785982; PMCID: PMC4584887.
Zhang D., Cheng C., Wang Y., Sun H., Yu S., Xue Y., Liu Y., Li W., Li X. 2020. Effect of Vitamin D on Blood Pressure and Hypertension in the General Population: An Update Meta-Analysis of Cohort Studies and Randomized Controlled Trials. Prev. Chronic. Dis., Jan 9; 17: E03. doi: 10.5888/pcd17.190307.
Seo J.A., Eun C.R., Cho H., Lee S.K., Yoo H.J., Kim S.G., Choi K.M., Baik S.H., Choi D.S., Yim H.J., Shin C., Kim N.H. 2013. Low vitamin D status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults. PLoS One. Oct 9; 8 (10): e75197. doi: 10.1371/journal.pone.0075197.